Atlas Trials

SarCaBon: A Randomised Phase II Trial of Saracatinib Versus Placebo for Cancer-induced Bone Pain

Clinical trial NCT02085603 · COMPLETED

Trial details

NCT number
NCT02085603
Sponsor
Sheffield Teaching Hospitals NHS Foundation Trust
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Cancer
Start date
2014-03-01
Primary completion
2018-01-21
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.